Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Kitamura

Showing results (221-230 of 240) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Investigation|November 13, 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDaichi Inoue, Jiro Kitaura, Katsuhiro Togami, et al.
Nature|June 13, 2003
Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsToshimasa Yamauchi, Junji Kamon, Yusuke Ito, et al.
Nature Communications|March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathwayTakeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Cell Reports|March 6, 2026
IgE-dependent anaphylaxis is regulated by sphingolipid binding to activating and inhibitory CD300 family membersKumi Izawa, Ayako Kaitani, Yutaka Enomoto, et al.
Blood|June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Cell Death & Disease|July 24, 2019
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumorsIsabella Orienti, Federica Francescangeli, Maria Laura De Angelis, et al.
Nature Cardiovascular Research|December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunityNaru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
Scientific Reports|June 29, 2017
Disrupting ceramide-CD300f interaction prevents septic peritonitis by stimulating neutrophil recruitmentKumi Izawa, Akie Maehara, Masamichi Isobe, et al.
Blood|April 25, 2018
Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphomaHiroshi Higuchi, Natsuko Yamakawa, Ken-Ichi Imadome, et al.
The Journal of Clinical Investigation|May 23, 2017
Genetic regulation of the RUNX transcription factor family has antitumor effectsKen Morita, Kensho Suzuki, Shintaro Maeda, et al.
Pageof 24

Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Investigation|November 13, 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDaichi Inoue, Jiro Kitaura, Katsuhiro Togami, et al.
Nature|June 13, 2003
Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsToshimasa Yamauchi, Junji Kamon, Yusuke Ito, et al.
Nature Communications|March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathwayTakeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Cell Reports|March 6, 2026
IgE-dependent anaphylaxis is regulated by sphingolipid binding to activating and inhibitory CD300 family membersKumi Izawa, Ayako Kaitani, Yutaka Enomoto, et al.
Blood|June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Cell Death & Disease|July 24, 2019
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumorsIsabella Orienti, Federica Francescangeli, Maria Laura De Angelis, et al.
Nature Cardiovascular Research|December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunityNaru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
Scientific Reports|June 29, 2017
Disrupting ceramide-CD300f interaction prevents septic peritonitis by stimulating neutrophil recruitmentKumi Izawa, Akie Maehara, Masamichi Isobe, et al.
Blood|April 25, 2018
Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphomaHiroshi Higuchi, Natsuko Yamakawa, Ken-Ichi Imadome, et al.
The Journal of Clinical Investigation|May 23, 2017
Genetic regulation of the RUNX transcription factor family has antitumor effectsKen Morita, Kensho Suzuki, Shintaro Maeda, et al.
Pageof 24